These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2207109)

  • 1. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases.
    Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT
    Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the specificity of barley chymotrypsin inhibitor 2 by cysteine engineering of the P1 residue.
    Hasan Z; Leatherbarrow RJ
    Biochim Biophys Acta; 1998 May; 1384(2):325-34. PubMed ID: 9659394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and kinetic characterization of barley chymotrypsin inhibitors 1a and 1b.
    Greagg MA; Brauer AB; Leatherbarrow RJ
    Biochim Biophys Acta; 1994 Jun; 1222(2):179-86. PubMed ID: 8031854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel double-headed proteinaceous inhibitor for metalloproteinase and serine proteinase.
    Hiraga K; Suzuki T; Oda K
    J Biol Chem; 2000 Aug; 275(33):25173-9. PubMed ID: 10827083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the C-terminal region of yeast proteinase B inhibitor 2 in its inhibitory action.
    Kojima S; Deguchi M; Miura K
    J Mol Biol; 1999 Feb; 286(3):775-85. PubMed ID: 10024450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of residues in the reactive site loop of chymotrypsin inhibitor 2 to protein stability and activity.
    Jackson SE; Fersht AR
    Biochemistry; 1994 Nov; 33(46):13880-7. PubMed ID: 7947796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a small peptide-based proteinase inhibitor by modeling the active-site region of barley chymotrypsin inhibitor 2.
    Leatherbarrow RJ; Salacinski HJ
    Biochemistry; 1991 Nov; 30(44):10717-21. PubMed ID: 1931991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The propeptide of subtilisin BPN' as a temporary inhibitor and effect of an amino acid replacement on its inhibitory activity.
    Kojima S; Minagawa T; Miura K
    FEBS Lett; 1997 Jul; 411(1):128-32. PubMed ID: 9247157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary structure and inhibitory properties of a subtilisin-chymotrypsin inhibitor from Streptomyces virginiae.
    Terabe M; Kojima S; Taguchi S; Momose H; Miura K
    Eur J Biochem; 1994 Dec; 226(2):627-32. PubMed ID: 8001578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
    Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of subtilisin BPN' and recombinant Streptomyces subtilisin inhibitors with substituted P1 site residues.
    Masuda-Momma K; Hatanaka T; Inouye K; Kanaori K; Tamura A; Akasaka K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Oct; 114(4):553-9. PubMed ID: 8276767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the intramolecular hydrogen bond network in the inhibitory power of chymotrypsin inhibitor 2.
    Radisky ES; Lu CJ; Kwan G; Koshland DE
    Biochemistry; 2005 May; 44(18):6823-30. PubMed ID: 15865427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the propeptide of subtilisin E as an intramolecular chaperone for protein folding. Refolding and inhibitory abilities of propeptide mutants.
    Li Y; Hu Z; Jordan F; Inouye M
    J Biol Chem; 1995 Oct; 270(42):25127-32. PubMed ID: 7559646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.